Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
26418 | 255 | 27.2 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
236 | 3 | ADENOSINE//NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//ADENOSINE RECEPTORS | 48331 |
793 | 2 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//NUCLEOSIDES//CARBOCYCLIC NUCLEOSIDES | 12112 |
26418 | 1 | TAS 106//DUPLEX DRUG//3 C ETHYNYLCYTIDINE | 255 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TAS 106 | authKW | 1317210 | 4% | 100% | 11 |
2 | DUPLEX DRUG | authKW | 851528 | 3% | 89% | 8 |
3 | 3 C ETHYNYLCYTIDINE | authKW | 538856 | 2% | 75% | 6 |
4 | ECYD | authKW | 538856 | 2% | 75% | 6 |
5 | ORGANOSILICON REAGENT | authKW | 498941 | 2% | 83% | 5 |
6 | ORGANOALUMINUM REAGENT | authKW | 478985 | 2% | 100% | 4 |
7 | 3 ETHYNYLCYTIDINE | authKW | 359239 | 1% | 100% | 3 |
8 | 4 C SUBSTITUTED 2 DEOXYNUCLEOSIDE | authKW | 359239 | 1% | 100% | 3 |
9 | CS 682 | authKW | 359239 | 1% | 100% | 3 |
10 | DIDEHYDRO 3 DEOXYTHYMIDINE | authKW | 359239 | 1% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Organic | 1418 | 34% | 0% | 87 |
2 | Chemistry, Medicinal | 266 | 10% | 0% | 26 |
3 | Oncology | 232 | 17% | 0% | 44 |
4 | Biochemistry & Molecular Biology | 215 | 27% | 0% | 69 |
5 | Pharmacology & Pharmacy | 182 | 18% | 0% | 45 |
6 | Microbiology | 34 | 6% | 0% | 16 |
7 | Chemistry, Applied | 11 | 3% | 0% | 7 |
8 | Chemistry, Inorganic & Nuclear | 8 | 3% | 0% | 8 |
9 | Biophysics | 5 | 3% | 0% | 7 |
10 | Virology | 5 | 2% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EXPT RETROVIROL SECT | 227046 | 6% | 12% | 16 |
2 | ANTIVIRAL CHEMOTHER Y | 122272 | 5% | 9% | 12 |
3 | 11 TSUTSUMIDORI AMAMIYA | 119746 | 0% | 100% | 1 |
4 | CANC DESIGNATED COMPREHENS CANC | 119746 | 0% | 100% | 1 |
5 | CHEM PHARM FOOD SCI | 119746 | 0% | 100% | 1 |
6 | IMMUNOPATHOL INTERNAL MED 2 | 119746 | 0% | 100% | 1 |
7 | LICENSE DEV | 119746 | 0% | 100% | 1 |
8 | PHARMACOL EXPT CLINIQUE | 119746 | 0% | 100% | 1 |
9 | STATE ONCOL SO CHINASIR YK PAO CANC | 119746 | 0% | 100% | 1 |
10 | U716 IGM | 119746 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 37126 | 15% | 1% | 38 |
2 | INVESTIGATIONAL NEW DRUGS | 2290 | 3% | 0% | 7 |
3 | LANCET HIV | 1149 | 0% | 1% | 1 |
4 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1122 | 6% | 0% | 15 |
5 | TETRAHEDRON-ASYMMETRY | 731 | 3% | 0% | 8 |
6 | BIOORGANIC & MEDICINAL CHEMISTRY | 441 | 3% | 0% | 7 |
7 | JOURNAL OF MEDICINAL CHEMISTRY | 439 | 4% | 0% | 9 |
8 | HOSPITAL FORMULARY | 350 | 0% | 0% | 1 |
9 | JOURNAL OF ORGANIC CHEMISTRY | 320 | 5% | 0% | 12 |
10 | CHINESE JOURNAL OF CANCER | 301 | 0% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TAS 106 | 1317210 | 4% | 100% | 11 | Search TAS+106 | Search TAS+106 |
2 | DUPLEX DRUG | 851528 | 3% | 89% | 8 | Search DUPLEX+DRUG | Search DUPLEX+DRUG |
3 | 3 C ETHYNYLCYTIDINE | 538856 | 2% | 75% | 6 | Search 3+C+ETHYNYLCYTIDINE | Search 3+C+ETHYNYLCYTIDINE |
4 | ECYD | 538856 | 2% | 75% | 6 | Search ECYD | Search ECYD |
5 | ORGANOSILICON REAGENT | 498941 | 2% | 83% | 5 | Search ORGANOSILICON+REAGENT | Search ORGANOSILICON+REAGENT |
6 | ORGANOALUMINUM REAGENT | 478985 | 2% | 100% | 4 | Search ORGANOALUMINUM+REAGENT | Search ORGANOALUMINUM+REAGENT |
7 | 3 ETHYNYLCYTIDINE | 359239 | 1% | 100% | 3 | Search 3+ETHYNYLCYTIDINE | Search 3+ETHYNYLCYTIDINE |
8 | 4 C SUBSTITUTED 2 DEOXYNUCLEOSIDE | 359239 | 1% | 100% | 3 | Search 4+C+SUBSTITUTED+2+DEOXYNUCLEOSIDE | Search 4+C+SUBSTITUTED+2+DEOXYNUCLEOSIDE |
9 | CS 682 | 359239 | 1% | 100% | 3 | Search CS+682 | Search CS+682 |
10 | DIDEHYDRO 3 DEOXYTHYMIDINE | 359239 | 1% | 100% | 3 | Search DIDEHYDRO+3+DEOXYTHYMIDINE | Search DIDEHYDRO+3+DEOXYTHYMIDINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ABDELRAHIM, M , MATSUDA, A , NAING, A , (2013) TAS-106: PRECLINICAL, CLINICAL AND BEYOND.ONCOLOGY. VOL. 85. ISSUE 6. P. 356-363 | 29 | 76% | 4 |
2 | OHRUI, H , (2011) DEVELOPMENT OF MODIFIED NUCLEOSIDES THAT HAVE SUPREMELY HIGH ANTI-HIV ACTIVITY AND LOW TOXICITY AND PREVENT THE EMERGENCE OF RESISTANT HIV MUTANTS.PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES. VOL. 87. ISSUE 3. P. 53 -65 | 20 | 77% | 5 |
3 | OHRUI, H , HAYAKAWA, H , KOHGO, S , MATSUOKA, M , KODAMA, E , MITSUYA, H , (2006) CREATION OF LOW TOXIC REVERSE-TRANSCRIPTASE INHIBITORY NUCLEOSIDES THAT PREVENT THE EMERGENCE OF DRUG-RESISTANT HIV VARIANTS.JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN. VOL. 64. ISSUE 7. P. 716 -723 | 13 | 93% | 3 |
4 | OHRUI, H , (2006) 2 '-DEOXY-4 '-C-ETHYNYL-2-FLUOROADENOSINE, A NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR, IS HIGHLY POTENT AGAINST ALL HUMAN IMMUNODEFICIENCY VIRUSES TYPE 1 AND HAS LOW TOXICITY.CHEMICAL RECORD. VOL. 6. ISSUE 3. P. 133 -143 | 15 | 75% | 15 |
5 | ICHIKAWA, S , MINAKAWA, N , SHUTO, S , TANAKA, M , SASAKI, T , MATSUDA, A , (2006) SYNTHESIS OF 3 '-BETA-CARBAMOYLMETHYLCYTIDINE (CAMC) AND ITS DERIVATIVES AS POTENTIAL ANTITUMOR AGENTS.ORGANIC & BIOMOLECULAR CHEMISTRY. VOL. 4. ISSUE 7. P. 1284 -1296 | 24 | 45% | 8 |
6 | BETSON, M , ALLANSON, N , WAINWRIGHT, P , (2014) A REVIEW OF METHODS TO SYNTHESISE 4 '-SUBSTITUTED NUCLEOSIDES.ORGANIC & BIOMOLECULAR CHEMISTRY. VOL. 12. ISSUE 46. P. 9291 -9306 | 20 | 43% | 3 |
7 | HARAGUCHI, K , TAKEDA, S , KUBOTA, Y , KUMAMOTO, H , TANAKA, H , HAMASAKI, T , BABA, M , PAINTSIL, E , CHENG, YC , (2013) FROM THE CHEMISTRY OF EPOXY-SUGAR NUCLEOSIDES TO THE DISCOVERY OF ANTI-HIV AGENT 4 '-ETHYNYLSTAVUDINE-FESTINAVIR.CURRENT PHARMACEUTICAL DESIGN. VOL. 19. ISSUE 10. P. 1880-1897 | 21 | 39% | 7 |
8 | SCHOTT, H , SCHOTT, S , SCHWENDENER, RA , (2009) SYNTHESIS AND IN VITRO ACTIVITIES OF NEW ANTICANCER DUPLEX DRUGS LINKING 2 '-DEOXY-5-FLUOROURIDINE (5-FDU) WITH 3 '-C-ETHYNYLCYTIDINE (ECYD) VIA A PHOSPHODIESTER BONDING.BIOORGANIC & MEDICINAL CHEMISTRY. VOL. 17. ISSUE 19. P. 6824 -6831 | 13 | 68% | 7 |
9 | TSAO, A , HUI, EP , JUERGENS, R , MARUR, S , HUAT, TE , CHER, GB , HONG, RL , HONG, WK , CHAN, ATC , (2013) PHASE II STUDY OF TAS-106 IN PATIENTS WITH PLATINUM-FAILURE RECURRENT OR METASTATIC HEAD AND NECK CANCER AND NASOPHARYNGEAL CANCER.CANCER MEDICINE. VOL. 2. ISSUE 3. P. 351-359 | 13 | 62% | 3 |
10 | LIU, P , SHARON, A , CHU, CK , (2006) ENANTIOMERIC SYNTHESIS OF CARBOCYCLIC D-4 '-C-METHYL-RIBONUCLEOSIDES AS POTENTIAL ANTIVIRAL AGENTS.TETRAHEDRON-ASYMMETRY. VOL. 17. ISSUE 23. P. 3304 -3314 | 18 | 53% | 3 |
Classes with closest relation at Level 1 |